The Rest Of Asia Pacific Artificial Intelligence (AI) in Medical Diagnostics Market was valued at $72 Million in 2024 and projected to reach to $174.9 Million by 2029, representing a compound annual growth rate of 19.4%. Rest Of Asia Pacific is positioned as a high-growth frontier for AI-driven medical diagnostics, with market dynamics shaped by rapid healthcare digitalization, increasing diagnostic demands, and growing technology adoption across emerging economies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific's AI medical diagnostics market is experiencing accelerated growth at 19.4% CAGR, expanding from $72.0 million in 2024 to $174.9 million by 2029, driven by healthcare infrastructure modernization across emerging economies.
Increasing adoption of digital health infrastructure in Rest Of Asia Pacific countries is creating substantial opportunities for AI-powered diagnostic solutions, particularly in imaging and pathology applications across hospitals and diagnostic centers.
Rising patient volumes and limited specialist availability in Rest Of Asia Pacific are driving demand for AI solutions that enhance diagnostic accuracy, reduce turnaround times, and improve clinical outcomes in resource-constrained healthcare settings.
Rest Of Asia Pacific represents an untapped growth frontier with developing economies investing heavily in healthcare technology, creating favorable conditions for AI diagnostic tool penetration and market consolidation opportunities.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | SERVICES (Component) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 22.5% from 2024 to 2029 |
| Largest Segment | IN VIVO DIAGNOSTICS (Application) |
| Market Size Base Year (Billions) | ~USD 1.71 (2024) |
| Revenue Forecast (Billions) | ~USD 4.72 (2029) |
| Segments Covered | Component, Type, End User, Modality, Modality Type, Application, Type 2023-2029, Processor Type, Network Type, Type 2017-2022, Segment |
11 segment dimensions are covered across the global market.
Rest Of Asia Pacific's AI medical diagnostics market was valued at $72.0 million in 2024 and is forecast to reach $174.9 million by 2029.
Rest Of Asia Pacific's AI medical diagnostics market is growing at a compound annual growth rate (CAGR) of 19.4% from 2024 to 2029.
Rest Of Asia Pacific's growth is driven by healthcare infrastructure modernization, increasing diagnostic demand, cost-sensitive delivery models, and partnerships with global AI vendors.
Rest Of Asia Pacific is seeing strong adoption of AI-powered imaging analysis, pathology automation, and screening solutions that address high disease burden and diagnostic bottlenecks.
Rest Of Asia Pacific countries are progressively establishing regulatory frameworks and clinical validation pathways that are expected to accelerate AI diagnostic tool adoption through 2029.
To balance primary and secondary research for the AI in Medical Diagnotics market, different market variables for small and medium-sized businesses and major businesses were analyzed as part of this study. The next step involved primary research with industry experts along the value chain to validate these findings, assumptions, and market sizing. Many different methodologies were used for estimating the overall market size, involving the top-down and bottom-up approaches. The study consists of significant market segments, evolving patterns, regulatory frameworks, and competitive environments. This study also considers leading market players and the strategies they deploy in this market. In conclusion, the total market size was estimated through top-down and bottom-up approaches along with data triangulation to reach the number for the final market size. Primary research was conducted throughout the study to validate and test each hypothesis.
The secondary sources referred to for this research study include publications from government sources, directories, and databases (Dun & Bradstreet, Bloomberg Businessweek, and Factiva, among others) to identify and collect information useful for the technical, market-oriented, and commercial study of AI in medical diagnostics market. Secondary data was collected and analyzed to arrive at the overall size of the global AI in medical diagnostics market, which was validated through primary research.
Extensive primary research was conducted after acquiring basic knowledge about the global of AI in medical diagnostics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Hospitals, Clinics and Other Healthcare Facilities, Diagnostic laboratories and Diagnostics Imaging Center, Other End Users- Employer Groups and Government Bodies) and supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, and Rest of the world. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
Note 1: C-level primaries include CEOs, CFOs, and COOs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
As per the review of prominent companies and their revenue shares, the market size of the global AI in medical diagnostics market was calculated in this report. Key players with significant shares in the market were identified as part of secondary research and their medical diagnostics business revenue was calculated, primaries validated the same. Analyzing the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, in-depth interviews with important thought leaders, including directors, CEOs, and marketing executives, were a part of the primary study.
Both top-down and bottom-up approaches were used to estimate and validate the size of the AI in medical diagnostics market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details:
AI in medical diagnostics Market Size: Market Estimation Approach

To estimate the overall market size of the AI in medical diagnostics market, a detailed market size estimation process was followed. The market was then segmented into various segments and subsegments for more precise analysis. To ensure accuracy, data triangulation and market breakdown methodologies were applied where applicable. This approach involved analyzing various factors and trends from both the demand and supply sides, providing comprehensive and reliable insights into the market.
Artificial intelligence (AI) refers to the theory and development of computer systems capable of performing tasks that usually require human intelligence. AI involves the study & synthesis of intelligent agents—in this case, a computer system. The system perceives its environment and takes appropriate action to maximize success. AI is being developed to create expert systems and improve human intelligence in machines.
AI is used in the medical diagnostics market to analyze complex data from various imaging modalities and help end users interpret critical data points to diagnose disease conditions.
Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Medical Diagnostics Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report